KDR and tuberculosis: Loss of Cxcr4b function limits granuloma expansion to a similar degree as Vegfr blockade, suggesting CXCR4 inhibition as an alternative host-directed therapeutic approach for TB treatment without side effects on physiological angiogenesis.